Skip to main content

Alx Oncology Holdings Inc

ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810182

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Alx Oncology Holdings Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
96
−11 vs. Q4 2021
Shares held
36.8M
+525.4K (+1.4%) vs. Q4 2021
Total value
$621.9M
−$157.5M (−20.2%) vs. Q4 2021
New holders
10
32 more added
Sold out
21
34 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 96 institutions
Q1 2021: 94 institutionsQ2 2021: 105 institutionsQ3 2021: 115 institutionsQ4 2021: 108 institutionsQ1 2022: 96 institutionsQ2 2022: 97 institutionsQ3 2022: 99 institutionsQ4 2022: 87 institutionsQ1 2023: 86 institutionsQ2 2023: 75 institutionsQ3 2023: 76 institutionsQ4 2023: 93 institutionsQ1 2024: 106 institutionsQ2 2024: 112 institutionsQ3 2024: 92 institutionsQ4 2024: 87 institutionsQ1 2025: 85 institutionsQ2 2025: 61 institutionsQ3 2025: 61 institutionsQ4 2025: 57 institutionsQ1 2026: 69 institutionsQ2 2026: 93 institutions
Value heldQ1 2022: $621.9M
Q1 2021: $2.47BQ2 2021: $1.82BQ3 2021: $2.55BQ4 2021: $780.0MQ1 2022: $621.9MQ2 2022: $290.7MQ3 2022: $348.7MQ4 2022: $410.6MQ1 2023: $161.4MQ2 2023: $257.5MQ3 2023: $159.8MQ4 2023: $681.5MQ1 2024: $510.5MQ2 2024: $293.4MQ3 2024: $82.7MQ4 2024: $68.5MQ1 2025: $21.7MQ2 2025: $12.1MQ3 2025: $50.8MQ4 2025: $33.0MQ1 2026: $189.0MQ2 2026: $217.9M
Institutions holding ALXO and their total value by quarter
QuarterHoldersValue
Q2 202693$217.9M
Q1 202669$189.0M
Q4 202557$33.0M
Q3 202561$50.8M
Q2 202561$12.1M
Q1 202585$21.7M
Q4 202487$68.5M
Q3 202492$82.7M
Q2 2024112$293.4M
Q1 2024106$510.5M
Q4 202393$681.5M
Q3 202376$159.8M
Q2 202375$257.5M
Q1 202386$161.4M
Q4 202287$410.6M
Q3 202299$348.7M
Q2 202297$290.7M
Q1 202296$621.9M
Q4 2021108$780.0M
Q3 2021115$2.55B
Q2 2021105$1.82B
Q1 202194$2.47B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q4 2021.

Institutions holding ALXO in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Nomura Holdings Inc0$00.00%−26,424−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−24,203−100.0%Sold out
First Trust Advisors LP0$00.00%−21,777−100.0%Sold out
Twinbeech Capital LP0$00.00%−21,500−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−19,190−100.0%Sold out
Atom Investors LP0$00.00%−15,477−100.0%Sold out
PDT Partners, LLC0$00.00%−15,154−100.0%Sold out
Teachers Retirement System of the State of Kentucky0$00.00%−11,471−100.0%Sold out
Engineers Gate Manager LP0$00.00%−10,700−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−9,857−100.0%Sold out
ProShare Advisors LLC0$00.00%−9,579−100.0%Sold out
Erste Asset Management GmbH0$00.00%−9,200−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−611−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−131−100.0%Sold out
Andrew Hill Investment Advisors, Inc.0$00.00%−100−100.0%Sold out
Captrust Financial Advisors0$00.00%−13−100.0%Sold out
Covestor Ltd0$00.00%−8−100.0%Sold out
AlphaCentric Advisors LLC––––Not filed